Navigation Links
VaxGen in Medical News

FDA Warns VaxGen On Anthrax Vaccine

The Food and Drug Administration has warned the manufacturers of a new vaccine for anthrax for making false claims about the purity and effectiveness// of the vaccine. VaxGen Inc was accused of inflating the claims based on a few studies, the data for which is not enough for issuing such statements...

VaxGen Provides Financial Update Following the Filing of Its 10-Q for Second Quarter With SEC; Results Include $8.5 Million Charge in Respect of Manufacturing Plant Asset Impairment

...w.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO ) vaxgen had approximately $59 million in cash and equivale...any's $30 million of outstanding convertible debt. vaxgen reported a net loss for the second quarter of $10....agreed to terms, for reasons entirely unrelated to vaxgen or the plant. In light of this, however, our expec...

New HIV browser gives researchers access to valuable data from vaccine trials

...raphic and clinical data from volunteers who became HIV infected during the vaxgen clinical trial. The browser allows users to align viral sequences with one ...quence data from infected participants in the Phase III clinical trial that vaxgen conducted in Thailand. "In the future, the database will be expanded to...

VaxGen Restructures Following Termination of Proposed Merger

...ger between VaxGen and Raven biotechnologies, inc. vaxgen has moved to terminate the staff which it had reta...n of the needs of the merged company. As a result, vaxgen will be terminating approximately 75% of its remai...91112/VAXGENLOGO ) "It is quite unfortunate that vaxgen must now terminate so many of our most capable and...

VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven

.../ -- VaxGen Inc. (OTC Bulletin Board: VXGN) Dear vaxgen Stockholder, March 28th marks the date of the Sp...cial Stockholder meeting and the conclusion of the vaxgen stockholder vote on the proposed VaxGen-Raven merg...ity of the votes cast in person or by proxy at the vaxgen special meeting is required for approval of the me...

VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement

...sed Transaction Under the terms of the agreement, vaxgen shall issue, and the holders of Raven Series D pre...ee transaction, approximately 32 million shares of vaxgen common stock. Following the closing of the transaction, vaxgen stockholders will own approximately 51 percent of ...

An alternative vaccine to combat Anthrax

...e using this data to help design strategies for testing of this vaccine in the future." Gorse indicated that the investigational vaccine, made by vaxgen Inc., demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response. The study was designed to e...

Two AIDS Vaccine Trials Hold Hope Against Epidemic

...n South America and the Caribbean, is an improvement over the disappointing vaxgen that came to a dead end in Thailand in 2003, Koff said. Tests on the ...y miraculous," Nabel told DPA. In addition, a modified version of the vaxgen trials continues on 16,000 volunteers in Thailand, who are receiving an add...
VaxGen in Medical Technology

Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer

...therapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast and ovarian cancer. On November 12, 2007, Raven and vaxgen Inc. (OTC: VXGN.PK), a biopharmaceutical company, announced that their respective boards of directors unanimously approved a definitive merger agreeme...

GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials

...ials. Only a handful of AIDS vaccines have reached the Phase 2 level of clinical evaluation with the HVTN, including the previously failed vaccines of vaxgen and Merck," stated GeoVax President, Don Hildebrand. GeoVax has completed two Phase 1 human trials evaluating its AIDS vaccines with excellent resul...

ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.

..., today announced it has finalized a Material Transfer Agreement (MTA) with vaxgen Inc. (Pink Sheets: VXGN.PK). As part of the agreement, ImmuneRegen will rec...nd, Viprovex, will demonstrate adjuvant activity in a rabbit model with the vaxgen vaccine," said Hal Siegel, Ph.D., Senior Director of Product Development an...
VaxGen in Biological News

Combating anthrax: Results of study published this month as researchers look for a better vaccine

... be using this data to help design strategies for testing of this vaccine in the future." Gorse indicated that the investigational vaccine, made by vaxgen Inc., demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response. The study was designed to ev...
VaxGen in Biological Technology

VaxGen Restructures Board of Directors

.../VAXGENLOGO ) In conjunction with these changes, vaxgen is reconstituting the Strategic Transactions Commi...logy transaction experience." said James P. Panek, vaxgen President and CEO. "I am delighted to welcome two ...ice over the past several years." About VaxGen vaxgen is a biopharmaceutical company based in South San ...

Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance

... recent restructuring undertaken on April 9, 2008. vaxgen expects that its average monthly cash expenditures... the Company's sole control," said James P. Panek, vaxgen President and CEO. "While we continue to explore e...ovide assurance that a transaction will result." vaxgen further announced today the filing of its financia...

VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.

...rms of the transaction, Emergent BioSolutions paid vaxgen $2 million upon execution of the definitive agreem...of returns for our shareholders." About VaxGen vaxgen is a biopharmaceutical company based in South San ...ts that speak only as of the date of this release. vaxgen undertakes no obligation to update publicly any fo...

VaxGen and Raven Terminate Merger Agreement

...n anticipated opposition to the proposed merger by vaxgen stockholders. In addition, VaxGen's Board has with...related equity plan proposals would be rejected by vaxgen stockholders. (Logo: http://www.newscom.com/cgi...on, such that this merger will not be approved." vaxgen intends to open the Special Meeting of Stockholder...

VaxGen Issues Rebuttal to MedCap Letter

...en would represent a fairly disastrous outcome for vaxgen and would view it as a clear signal to sell VaxGen...le are discussed in the addendum to this letter. vaxgen believes these recent communications from MedCap s...way the VaxGen-Raven merger vote any way they can. vaxgen believes this includes the use of flawed arguments...

VaxGen Common Stock Now Quoted on OTC Bulletin Board

...iegel and Company is the market maker and assisted vaxgen with the qualification process. (Logo: http://w...e closing condition to the proposed merger between vaxgen and Raven requiring that VaxGen be listed on an ap...s to vote on the proposed merger. About VaxGen vaxgen is a biopharmaceutical company based in South San ...

Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO

...tic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. On November 12, 2007, Raven and vaxgen Inc. (Pink Sheets: VXGN.PK), a biopharmaceutical company, announced that their respective boards of directors unanimously approved a definitive merger...

VaxGen Reports Financial Update

...gi-bin/prnh/19991112/VAXGENLOGO ) Specifically, vaxgen announced the following: -- Cash, cash equivalent...s current best estimate of fair market value. vaxgen has not yet received an offer for the manufact...tion at this reduced value, or indeed at all. vaxgen expects to file its 2007 financial statements ...

Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations

...herapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, and ovarian cancer. On November 12, 2007, Raven and vaxgen Inc. (Pink Sheets: VXGN), a biopharmaceutical company, announced that their respective boards of directors unanimously approved a definitive merger ag...

VaxGen to Present at the 10th Annual BIO CEO and Investor Conference

...ter the live presentation. About VaxGen vaxgen is a biopharmaceutical company based in South San ...ts that speak only as of the date of this release. vaxgen and Raven undertake no obligation to update public...w. Additional Information and Where to Find It vaxgen has filed a registration statement on Form S-4, an...
Other Tags
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together by ... up to 30lbs in less than 12 weeks without traditional ... prompting an investigative review. , “Our Incredible Bulk review ... that allows the body to pack on a massive amount ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and easy ... treat specific body parts and muscle groups. , IsoComforter, ... use patented cold therapy machine with the innovative IsoTube design ... injuries. IsoComforter has become the industry leader in cold ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for ... its latest collection of wedding dresses , and launches ... is the wedding dress on your big day; the wedding ... Every bride wants to find the most suitable wedding dress. ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a technology ... measures the overall facial feature of a person such ...
(Date:12/11/2014)...  That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
Other Contents